Cargando…
Sulodexide increases mRNA expression of glutathione-related genes in human umbilical endothelial cells exposed to oxygen-glucose deprivation
INTRODUCTION: Sulodexide (SDX), a heparinoid used to treat vascular diseases, exerts anti-ischemic properties. However, the underlying molecular mechanisms remain unclear. Induction of glutathione (GSH)-dependent genes protects against ischemia. Here, we investigated the effect of SDX on GSH-associa...
Autores principales: | Gabryel, Bożena, Bontor, Klaudia, Urbanek, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667444/ https://www.ncbi.nlm.nih.gov/pubmed/33224345 http://dx.doi.org/10.5114/aoms.2019.87504 |
Ejemplares similares
-
Sulodexide up-regulates glutathione S-transferase P1 by enhancing Nrf2 expression and translocation in human umbilical vein endothelial cells injured by oxygen glucose deprivation
por: Gabryel, Bożena, et al.
Publicado: (2019) -
Sulodexide Increases Glutathione Synthesis and Causes Pro-Reducing Shift in Glutathione-Redox State in HUVECs Exposed to Oxygen–Glucose Deprivation: Implication for Protection of Endothelium against Ischemic Injury
por: Bontor, Klaudia, et al.
Publicado: (2022) -
Sulodexide reduces glucose induced senescence in human retinal endothelial cells
por: Gericke, A., et al.
Publicado: (2021) -
Sulodexide reduces senescence-related changes in human endothelial cells
por: Suminska-Jasinska, Katarzyna, et al.
Publicado: (2011) -
The renoprotective effects of sulodexide
por: Olde Engberink, Rik HG, et al.
Publicado: (2016)